About
Konstellate provides AI-driven KOL intelligence for pharmaceutical companies. Instead of searching fragmented sources, teams can ask targeted questions and receive attributed insights from verified expert content across publications, conferences, video, and audio. The platform identifies trends, sentiment shifts, and key opinion drivers to support faster, data-backed decisions in medical affairs and commercial strategy. Our platform allows you to create highly customized "workspaces" for specific therapeutic areas or drug candidates. You can set up real-time alerts for specific keywords or expert names to ensure you never miss a critical update. This granular control makes it the perfect tool for niche orphan drugs as well as massive primary care launches. We help you map the entire ecosystem of a disease state, from primary investigators to community influencers. Master your specific therapeutic domain with tools designed for deep scientific exploration.
Traction & Signals
Founded in 2025 (1 years), Konstellate is a small 2–5 person startup. Focused on sustainable growth and user expansion. The startup is currently in its seed stage and has not received any external funding.
Stripe data pending
This founder has not shared verified MRR publicly yet.
Affiliate Program
Konstellate provides AI-driven KOL intelligence for pharmaceutical companies. Instead of searching fragmented sources, teams can ask targeted questions and receive attributed insights from verified expert content across publications, conferences, video, and audio.
Perk
AI-powered KOL insights for pharma. Get fast, cited answers from verified expert discussions across media.